A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.

Francis Joseph Giles

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

7 Citations (Scopus)

Abstract

To investigate the toxicity profile, activity, pharmacokinetics, and pharmacodynamics of pemetrexed in leukemia.
Original languageEnglish (Ireland)
Number of pages9
JournalDrugs
Volume29
Issue number2
DOIs
Publication statusPublished - 1 Apr 2011

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Abdel-Karim I, Plunkett WK Jr, O'Brien S, Giles F, Thomas D, Faderl S, Ravandi F, Rios MB, Du M, Schneck KB, Chen VJ, Lin BK, Nicol SJ, Kantarjian HM

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Access to Document

Fingerprint

Dive into the research topics of 'A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.'. Together they form a unique fingerprint.
View full fingerprint

Cite this